Rigosertib for previously treated high-risk myelodysplastic syndrome [ID805]
Discontinued
Reference number: GID-TA10709
Following on from information provided to NICE by the company in December 2020, the appraisal of Rigosertib for previously treated high-risk myelodysplastic syndrome [ID805] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.